Moreover, while individual binding to each target occurs with moderate affinity, tumour cells expressing both antigens were bound with high affinity, indicating that the antibody, besides being able to inhibit the PD-1/PD-L1 axis, displays enhanced tumour selectivity. Here, CD274 is linked to neoplasm.